Literature DB >> 17454230

Neonatal hearing screening in Albania: results from an ongoing universal screening program.

Stavros Hatzopoulos1, Birkena Qirjazi, Alessandro Martini.   

Abstract

The paper describes the outcomes of an ongoing universal hearing screening program in Tirana, Albania. The main objectives of the project were the evaluation of the feasibility of a neonatal hearing screening program in Albania, and an evaluation of the prevalence of risk factors in the NICU environment. One thousand five hundred and sixty-one (1561) infants from both the WB and NICU were screened with transient evoked otoacoustic emissions (TEOAE). A detailed history of risk factors was collected in each case, thus it was possible to evaluate the main factors influencing the output of the screening program. It was concluded that the program had the capacity to identify infants with congenital hearing loss provided that an informative component is well-structured and delivered. Also, although the prevalence of risk factors appeared high, the reduction of 'case leakage' would allow the precise estimation of the incidence of hearing loss in the Albanian population.

Entities:  

Mesh:

Year:  2007        PMID: 17454230     DOI: 10.1080/14992020601145310

Source DB:  PubMed          Journal:  Int J Audiol        ISSN: 1499-2027            Impact factor:   2.117


  4 in total

1.  The influence of epidural anesthesia on new-born hearing screening: A pilot study.

Authors:  Katijah Khoza-Shangase; Karin Joubert
Journal:  J Pharm Bioallied Sci       Date:  2011-01

2.  Early detection of hearing loss.

Authors:  Götz Schade
Journal:  GMS Curr Top Otorhinolaryngol Head Neck Surg       Date:  2010-10-07

3.  [Not Available].

Authors:  Khoza-Shangase Katijah; Rifkind Romi Emma
Journal:  Afr J Infect Dis       Date:  2010

4.  Pediatric Physicians' Referral of Children Aged 0-3 Years for Audiological Evaluation in the Public Health Care Sector.

Authors:  Amisha Kanji; Razeena Kara
Journal:  Audiol Res       Date:  2013-11-22
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.